- Home
- ZDGE vs APLT Comparison
ZDGE vs APLT Comparison
Compare ZDGE & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZDGE
- APLT
- Stock Information
- Founded
- ZDGE 2008
- APLT 2016
- Country
- ZDGE United States
- APLT United States
- Employees
- ZDGE N/A
- APLT N/A
- Industry
- ZDGE Computer Software: Prepackaged Software
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- ZDGE Technology
- APLT Health Care
- Exchange
- ZDGE Nasdaq
- APLT Nasdaq
- Market Cap
- ZDGE 40.3M
- APLT 44.0M
- IPO Year
- ZDGE N/A
- APLT 2019
- Fundamental
- Price
- ZDGE $3.81
- APLT $0.41
- Analyst Decision
- ZDGE
- APLT Buy
- Analyst Count
- ZDGE 0
- APLT 7
- Target Price
- ZDGE N/A
- APLT $6.10
- AVG Volume (30 Days)
- ZDGE 419.5K
- APLT 2.6M
- Earning Date
- ZDGE 06-12-2025
- APLT 08-06-2025
- Dividend Yield
- ZDGE N/A
- APLT N/A
- EPS Growth
- ZDGE N/A
- APLT N/A
- EPS
- ZDGE N/A
- APLT N/A
- Revenue
- ZDGE $29,511,000.00
- APLT $265,000.00
- Revenue This Year
- ZDGE N/A
- APLT $1,768.13
- Revenue Next Year
- ZDGE $1.07
- APLT $292.85
- P/E Ratio
- ZDGE N/A
- APLT N/A
- Revenue Growth
- ZDGE 1.27
- APLT N/A
- 52 Week Low
- ZDGE $1.73
- APLT $0.30
- 52 Week High
- ZDGE $4.38
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- ZDGE 58.35
- APLT 58.87
- Support Level
- ZDGE $3.88
- APLT $0.32
- Resistance Level
- ZDGE $4.30
- APLT $0.36
- Average True Range (ATR)
- ZDGE 0.24
- APLT 0.04
- MACD
- ZDGE -0.06
- APLT 0.01
- Stochastic Oscillator
- ZDGE 18.05
- APLT 94.92
About ZDGE Zedge Inc. Class B
Zedge Inc provides content distribution platforms. Its content platform enables consumers to personalize their mobile devices with free, high-quality ringtones, wallpapers, home screen app icons, widgets and notification sounds as well as paint, a generative AI wallpaper maker, GuruShots, a skill-based photo challenge game, and Emojipedia. The company also launched a Zedge app. It has two reportable segments, which are the Zedge Marketplace and GuruShots.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.